Clinical relevance of heparanase mRNA expression in bladder cancer and its usefulness as a detection marker in voided urine

Molecular Medicine Reports

Volumn 2, Issue 2, 2009, Pages 327-331

  Zhao, Wei ^a   Wang, Xin Sheng ^b   Niu, Hai Tao ^b   Wang, Li Li ^a   Han, Bang Min ^a   Xia, Shu Jie ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Bladder cancer; Cytology; Diagnosis; Heparanase; RT PCR; Urine

Indexed keywords

HEPARANASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER RELAPSE; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MALE; NON INVASIVE PROCEDURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 69249085353     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000104     Document Type: Article

References (16)

1. Kim WJ and Bae SC: Molecular biomarkers in urothelial bladder cancer. Cancer Sci 99: 646-652, 2008.
2. Xu D-L, Hu Y, Tang X, Liu J and Xia S-J: Expression of vascular endothelial growth factors mRNA in tissues and urinary exfoliative cells in transitional bladder caicinoma and clinical significance. Chin J Exp Surg 20: 1068-1070, 2003.
3. Niu HT, Xu T, Zhang YB, Pang DQ, Zhang ZL, Wu S, Cheng B, Wang Y, Chang JW and Sun G: Outcomes for a large series of radical cystectomies for bladder cancer. Eur J Surg Oncol 34: 911-915, 2008.
4. Droller MJ: Current concepts of tumor markers in bladder cancer. Urol Clin North Am 29: 229-234, 2002.
5. Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R and Fuks Z: Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 9: 203-226, 1990.
6. Yanagishita M and Hascall VC: Cell surface heparan sulfate proteoglycans. J Biol Chem 267: 9451-9454, 1992.
7. Hulett MD, Freeman C and Hamdorf BJ: Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5: 803-809, 1999.
8. Donald S: The cytologic diagnosis of malignant neoplasm in pleural and peritoneal effusions. Acta Cytol 31: 85-88, 1987.
9. Vlodavsky I, Goldshmidt O, Zcharia E, Metzger S, Chajek-Shaul T, Atzmon R, Guatta-Rangini Z and Friedmann Y: Molecular properties and involvement of heparanase in cancer progression and normal development. Biochimie 83: 831-839, 2001.
10. Ferro V, Hammond E and Fairweather JK: The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation. Mini Rev Med Chem 4: 693-702, 2004.
11. Gilat D: Molecular behavior adapts to context: heparanase functions as an extracellular matrix degrading enzyme or as a T cell adhesion molecule depending on the local PH. J Exp Med 181: 1929-1931, 1995.
12. Shafat I, Zcharia E, Nisman B, Nadir Y, Nakhoul F, Vlodavsky I and Ilan N: An ELISA method for the detection and quantification of human heparanase. Biochem Biophy Res Commun 341: 958-963, 2006.
13. Shafat I, Pode D, Peretz T, Ilan N, Vlodavsky I and Nisman B: Clinical significance of urine heparanase in bladder cancer progression. Neoplasia 10: 125-130, 2008.
14. Halling KC and Kipp BR: Bladder cancer detection using FISH (UroVysion assay). Adv Anat Pathol 15: 279-286, 2008.
15. Dutta U and Poornachandra KS: Heparanase and gallbladder cancer: new insights into understanding tumor growth and invasion. J Gastroenterol Hepatol 23: 343-344, 2008.
16. McKenzie EA: Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 151: 1-14, 2007.